​
Login / Signup
Ariane Duverdier
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 6
Top Topics
Sleep Quality
Adverse Drug
End Stage Renal Disease
Patient Safety
Top Venues
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Clinical and translational allergy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ariane Duverdier
,
Guillem Hurault
,
Kim Suzanne Thomas
,
Adnan Custovic
,
Reiko J Tanaka
Evaluation of measurement errors in the Patient-Oriented Eczema Measure (POEM) outcome.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
54 (3) (2024)
Ariane Duverdier
,
Guillem Hurault
,
Kim Suzanne Thomas
,
Adnan Custovic
,
Reiko J Tanaka
Evaluation of measurement errors in the Patient-Oriented Eczema Measure (POEM) outcome.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
(2024)
Ariane Duverdier
,
Guillem Hurault
,
Kim Suzanne Thomas
,
Adnan Custovic
,
Reiko J Tanaka
Evaluation of measurement errors in the Patient-Oriented Eczema Measure (POEM) outcome.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
54 (3) (2024)
Ariane Duverdier
,
Guillem Hurault
,
Kim Suzanne Thomas
,
Adnan Custovic
,
Reiko J Tanaka
Evaluation of measurement errors in the Patient-Oriented Eczema Measure (POEM) outcome.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
54 (3) (2024)
Ariane Duverdier
,
Guillem Hurault
,
Kim Suzanne Thomas
,
Adnan Custovic
,
Reiko J Tanaka
Evaluation of measurement errors in the Patient-Oriented Eczema Measure (POEM) outcome.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
54 (3) (2024)
Ariane Duverdier
,
Adnan Custovic
,
Reiko J Tanaka
Data-driven research on eczema: Systematic characterization of the field and recommendations for the future.
Clinical and translational allergy
12 (6) (2022)